Johnson & Johnson Assets Held-for-sale, Not Part of Disposal Group, Current, Other
Johnson & Johnson (JNJ) had Assets Held-for-sale, Not Part of Disposal Group, Current, Other of $0 as of 2021-01-03, per its 10-K filed 2021-02-22.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther · last filed 2021-02-22
- 2021-01-03: Assets Held-for-sale, Not Part of Disposal Group, Current, Other $0.00.
- 2020-09-27: Assets Held-for-sale, Not Part of Disposal Group, Current, Other $91.00M.
- 2020-06-28: Assets Held-for-sale, Not Part of Disposal Group, Current, Other $100.00M.
- 2020-03-29: Assets Held-for-sale, Not Part of Disposal Group, Current, Other $102.00M.
| Period end | Assets Held-for-sale, Not Part of Disposal Group, Current, Other |
|---|---|
| 2021-01-03 | $0.00 10-K · filed 2021-02-22 |
| 2020-09-27 | $91.00M 10-Q · filed 2020-10-23 |
| 2020-06-28 | $100.00M 10-Q · filed 2020-07-24 |
| 2020-03-29 | $102.00M 10-Q · filed 2020-04-29 |
| 2019-12-29 | $94.00M 10-K · filed 2021-02-22 |
| 2019-09-29 | $194.00M 10-Q · filed 2019-10-28 |
| 2019-06-30 | $194.00M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $851.00M 10-Q · filed 2019-05-01 |
| 2018-12-30 | $950.00M 10-K · filed 2020-02-18 |
| 2018-09-30 | $2.21B 10-Q · filed 2018-10-31 |
| 2018-07-01 | $1.81B 10-Q · filed 2018-08-02 |
| 2018-04-01 | $1.74B 10-Q · filed 2018-05-01 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |